chr1-89009055-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018284.3(GBP3):āc.1551G>Cā(p.Glu517Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,614,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018284.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBP3 | NM_018284.3 | c.1551G>C | p.Glu517Asp | missense_variant | 10/11 | ENST00000370481.9 | NP_060754.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GBP3 | ENST00000370481.9 | c.1551G>C | p.Glu517Asp | missense_variant | 10/11 | 1 | NM_018284.3 | ENSP00000359512.4 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152228Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000203 AC: 51AN: 251314Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135820
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461800Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 26AN XY: 727206
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152346Hom.: 0 Cov.: 30 AF XY: 0.0000939 AC XY: 7AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | The c.1551G>C (p.E517D) alteration is located in exon 10 (coding exon 9) of the GBP3 gene. This alteration results from a G to C substitution at nucleotide position 1551, causing the glutamic acid (E) at amino acid position 517 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at